Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.44 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.32 |
| ▸ | GABRR2 | P28476 | 2/20 | 0.32 |
| ▸ | BLM | P54132 | 2/20 | 0.32 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.32 |
| ▸ | APEX1 | P27695 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL899316 | 1.00 | TSHR (0.44) | TSHRTP53EGLN1EGLN3LMNA | |
| SCHEMBL15754827 | 0.83 | TSHR (0.40) | TSHRTP53EGLN1EGLN3LMNA | |
| SCHEMBL29210964 | 0.81 | TSHR (0.38) | TSHRTP53EGLN1EGLN3LMNA | |
| SCHEMBL453090 | 0.80 | TSHR (0.42) | TSHRTP53EGLN1EGLN3LMNA | |
| SCHEMBL7821073 | 0.80 | TSHR (0.42) | TSHRTP53EGLN1EGLN3LMNA | |
| SCHEMBL9187017 | 0.80 | TSHR (0.42) | TSHRTP53EGLN1EGLN3LMNA | |
| SCHEMBL28564049 | 0.79 | THRB (0.46) | TSHRTP53EGLN1EGLN3LMNA | |
| SCHEMBL32685382 | 0.79 | THRB (0.46) | TSHRTP53EGLN1EGLN3LMNA | |
| SCHEMBL8830567 | 0.79 | THRB (0.46) | TSHRTP53EGLN1EGLN3LMNA | |
| SCHEMBL16178793 | 0.79 | THRB (0.46) | TSHRTP53EGLN1EGLN3LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4291587-A1 | PHOTOPOLYMERIZABLE HOE COMPOSITION | Xetos AG (DE) | 2023-12-20 | — | — | EP | disclosed |
| EP-4291951-A1 | TWO-COMPONENT SYSTEM | Xetos AG (DE) | 2023-12-20 | — | — | EP | disclosed |
| EP-4043502-B1 | PHOTOPOLYMERIZABLE HOE COMPOSITION | XETOS AG (DE) | 2023-10-04 | — | — | EP | disclosed |
| EP-4043961-B1 | 2K SYSTEM | XETOS AG (DE) | 2023-08-16 | — | — | EP | disclosed |
| EP-4043962-B1 | PHOTOPOLYMERIZABLE COMPOSITION | XETOS AG (DE) | 2023-06-07 | — | — | EP | disclosed |
| WO-2022171821-A1 | PHOTOPOLYMERIZABLE HOE COMPOSITION | XETOS AG (DE) | 2022-08-18 | — | — | WO | disclosed |
| WO-2022171823-A1 | PHOTOPOLYMERIZABLE COMPOSITION | XETOS AG (DE) | 2022-08-18 | — | — | WO | disclosed |
| WO-2022171814-A1 | TWO-COMPONENT SYSTEM | XETOS AG (DE) | 2022-08-18 | — | — | WO | disclosed |
| EP-4043961-A1 | 2K SYSTEM | Xetos AG (DE) | 2022-08-17 | — | — | EP | disclosed |
| EP-4043962-A1 | PHOTOPOLYMERIZABLE COMPOSITION | Xetos AG (DE) | 2022-08-17 | — | — | EP | disclosed |
| EP-2621903-A1 | N-HETEROARYL COMPOUNDS | Intervet International B.V. (NL) | 2013-08-07 | — | — | EP | disclosed |
| US-20130196993-A1 | N-HETEROARYL COMPOUNDS | INTERVET INC. | 2013-08-01 | — | — | US | disclosed |
| US-8431332-B2 | Composition for forming upper layer film for immersion exposure, upper layer film for immersion exposure, and method of forming photoresist pattern | JSR CORPORATION (JP) | 2013-04-30 | — | — | US | disclosed |
| WO-2012041873-A1 | N-HETEROARYL COMPOUNDS | INTERVET INTERNATIONAL B.V. (NL) | 2012-04-05 | — | — | WO | disclosed |
| EP-1438634-B1 | HOLOGRAPHIC RECORDING MATERIAL AND METHOD FOR CREATING A LIGHT-RESISTANT HOLOGRAM | XETOS AG (DE) | 2011-03-16 | — | — | EP | disclosed |
| US-20100255416-A1 | COMPOSITION FOR FORMING UPPER LAYER FILM FOR IMMERSION EXPOSURE, UPPER LAYER FILM FOR IMMERSION EXPOSURE, AND METHOD OF FORMING PHOTORESIST PATTERN | JSR CORPORATION (JP) | 2010-10-07 | — | — | US | disclosed |
| US-20100112458-A1 | Photopolymerisable composition | XETOS AG (DE) | 2010-05-06 | — | — | US | disclosed |
| US-20100040974-A1 | UPPER LAYER FILM FORMING COMPOSITION AND METHOD OF FORMING PHOTORESIST PATTERN | JSR CORPORATION (JP) | 2010-02-18 | — | — | US | disclosed |
| EP-1438634-A1 | HOLOGRAPHIC RECORDING MATERIAL AND METHOD FOR CREATING A LIGHT-RESISTANT HOLOGRAM | Xetos AG (DE) | 2004-07-21 | — | — | EP | disclosed |
| WO-2003036389-A1 | HOLOGRAPHIC RECORDING MATERIAL AND METHOD FOR CREATING A LIGHT-RESISTANT HOLOGRAM | XETOG AG (DE) | 2003-05-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130196993-A1 | N-HETEROARYL COMPOUNDS | HNMT, SQLE, PIGO | TSHR 4440/4885TP53 4822/4885EGLN1 696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.